Literature DB >> 8302319

Brief report: clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome.

E Cogan1, L Schandené, A Crusiaux, P Cochaux, T Velu, M Goldman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8302319     DOI: 10.1056/NEJM199402243300804

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  49 in total

Review 1.  Type I (insulin-dependent) diabetes is a Th1- and Th2-mediated autoimmune disease.

Authors:  S T Azar; H Tamim; H N Beyhum; M Z Habbal; W Y Almawi
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

2.  A rare manifestation of idiopathic hypereosinophilic syndrome: sclerosing cholangitis.

Authors:  Isabelle Delèvaux; Marc André; Jacques Chipponi; Anne-Marie Milési-Lecat; P Déchelotte; Olivier Aumaître
Journal:  Dig Dis Sci       Date:  2002-01       Impact factor: 3.199

3.  BIOMED-2 multiplex immunoglobulin/T-cell receptor polymerase chain reaction protocols can reliably replace Southern blot analysis in routine clonality diagnostics.

Authors:  Yorick Sandberg; Ellen J van Gastel-Mol; Brenda Verhaaf; King H Lam; Jacques J M van Dongen; Anton W Langerak
Journal:  J Mol Diagn       Date:  2005-10       Impact factor: 5.568

4.  T cell lymphoid aggregates in bone marrow in idiopathic hypereosinophilic syndrome.

Authors:  D Slater
Journal:  J Clin Pathol       Date:  1994-05       Impact factor: 3.411

5.  Hypereosinophilia in a patient with invasive thymoma with clonal T-lymphocyte expansion expressing CD4, CD8, and CD25 antigens.

Authors:  Masahiko Sumi; Kosuke Nunoda; Tomonori Mizutani; Yuko Ishii; Akihiko Gotoh; Yukihiko Kimura; Yasuhiro Suga; Tatsuo Ohira; Kuniharu Miyajima; Hiromi Serizawa; Kiyoshi Mukai; Harubumi Kato; Kazuma Ohyashiki
Journal:  Int J Hematol       Date:  2006-04       Impact factor: 2.490

6.  Idiopathic hypereosinophilic syndrome with skull base involvement.

Authors:  M L Battineni; S L Galetta; J Oh; M Lango; J J Brooks; S J Schuster; L A Loevner
Journal:  AJNR Am J Neuroradiol       Date:  2007-05       Impact factor: 3.825

Review 7.  Advances in diagnosis and treatment of eosinophilia.

Authors:  Javed Sheikh; Peter F Weller
Journal:  Curr Opin Hematol       Date:  2009-01       Impact factor: 3.284

Review 8.  Hypereosinophilic syndrome variants: diagnostic and therapeutic considerations.

Authors:  Florence Roufosse
Journal:  Haematologica       Date:  2009-09       Impact factor: 9.941

9.  Long-Term Clinical Outcomes of High-Dose Mepolizumab Treatment for Hypereosinophilic Syndrome.

Authors:  Fei Li Kuang; Michael P Fay; JeanAnne Ware; Lauren Wetzler; Nicole Holland-Thomas; Thomas Brown; Hector Ortega; Jonathan Steinfeld; Paneez Khoury; Amy D Klion
Journal:  J Allergy Clin Immunol Pract       Date:  2018-05-08

Review 10.  Biology of human TH1 and TH2 cells.

Authors:  S Romagnani
Journal:  J Clin Immunol       Date:  1995-05       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.